相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Function of Steroid Receptor Coactivator-1 in Normal Tissues and Cancer
Claire A. Walsh et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2012)
Niphatenones, Glycerol Ethers from the Sponge Niphates digitalis Block Androgen Receptor Transcriptional Activity in Prostate Cancer Cells: Structure Elucidation, Synthesis, and Biological Activity
Labros G. Meimetis et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
True Antiandrogens-Selective Non-Ligand-Binding Pocket Disruptors of Androgen Receptor-Coactivator Interactions: Novel Tools for Prostate Cancer
Laura Caboni et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Synthesis and Evaluation of Sulfonylnitrophenylthiazoles (SNPTs) as Thyroid Hormone Receptor-Coactivator Interaction Inhibitors
Jong Yeon Hwang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Discovery of the First Irreversible Small Molecule Inhibitors of the Interaction between the Vitamin D Receptor and Coactivators
Premchendar Nandhikonda et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Androgen receptor coregulators: Recruitment via the coactivator binding groove
Dennis J. van de Wijngaart et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2012)
A conserved surface on the ligand binding domain of nuclear receptors for allosteric control
Victor Buzon et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2012)
Allosteric Conversation in the Androgen Receptor Ligand-Binding Domain Surfaces
Solene Grosdidier et al.
MOLECULAR ENDOCRINOLOGY (2012)
Small Molecule Inhibitors Targeting the Achilles' Heel of Androgen Receptor Activity
Marianne D. Sadar
CANCER RESEARCH (2011)
Discovering Small-Molecule Estrogen Receptor α/Coactivator Binding Inhibitors: High-Throughput Screening, Ligand Development, and Models for Enhanced Potency
Aiming Sun et al.
CHEMMEDCHEM (2011)
Alternatively spliced androgen receptor variants
Scott M. Dehm et al.
ENDOCRINE-RELATED CANCER (2011)
Small Molecule Inhibitors as Probes for Estrogen and Androgen Receptor Action
David J. Shapiro et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Methylsulfonylnitrobenzoates, a New Class of Irreversible Inhibitors of the Interaction of the Thyroid Hormone Receptor and Its Obligate Coactivators That Functionally Antagonizes Thyroid Hormone
Jong Yeon Hwang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Inhibitors of Androgen Receptor Activation Function-2 (AF2) Site Identified through Virtual Screening
Peter Axerio-Cilies et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Targeting the Binding Function 3 (BF3) Site of the Human Androgen Receptor through Virtual Screening
Nathan A. Lack et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Design and Structure of Stapled Peptides Binding to Estrogen Receptors
Chris Phillips et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2011)
Identification of Ligand-Selective Peptide Antagonists of the Mineralocorticoid Receptor Using Phage Display
Jun Yang et al.
MOLECULAR ENDOCRINOLOGY (2011)
Small Molecule Inhibition of the Steroid Receptor Coactivators, SRC-3 and SRC-1
Ying Wang et al.
MOLECULAR ENDOCRINOLOGY (2011)
Targeting the regulation of androgen receptor signaling by the heat shock protein 90 cochaperone FKBP52 in prostate cancer cells
Johanny Tonos De Leon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Inhibition of Androgen Receptor Functions by Gelsolin FxxFF Peptide Delivered by Transfection, Cell-Penetrating Peptides, and Lentiviral Infection
Dennis J. van de Wijngaart et al.
PROSTATE (2011)
A Quantitative High-Throughput Screen Identifies Novel Inhibitors of the Interaction of Thyroid Receptor β with a Peptide of Steroid Receptor Coactivator 2
Ronald L. Johnson et al.
JOURNAL OF BIOMOLECULAR SCREENING (2011)
LXXLL peptide mimetics as inhibitors of the interaction of vitamin D receptor with coactivators
Yusuke Mita et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Regression of Castrate-Recurrent Prostate Cancer by a Small-Molecule Inhibitor of the Amino-Terminus Domain of the Androgen Receptor
Raymond J. Andersen et al.
CANCER CELL (2010)
Synthesis and Crystal Structure of a Phosphorylated Estrogen Receptor Ligand Binding Domain
Sabine Mocklinghoff et al.
CHEMBIOCHEM (2010)
Phage display selection of miniprotein binders of the Estrogen Receptor
Trang Phan et al.
CHEMICAL COMMUNICATIONS (2010)
Peptide Antagonist of the Androgen Receptor
Wenqing Gao
CURRENT PHARMACEUTICAL DESIGN (2010)
A Noncompetitive Small Molecule Inhibitor of Estrogen-regulated Gene Expression and Breast Cancer Cell Growth That Enhances Proteasome-dependent Degradation of Estrogen Receptor α
Nicole M. Kretzer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Steroid Receptor Coactivator (SRC) Family: Masters of Systems Biology
Brian York et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Structural Basis for Cyclic Py-Im Polyamide Allosteric Inhibition of Nuclear Receptor Binding
David M. Chenoweth et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study
Howard I. Scher et al.
LANCET (2010)
Anacardic Acid Inhibits Estrogen Receptor α-DNA Binding and Reduces Target Gene Transcription and Breast Cancer Cell Proliferation
David J. Schultz et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Minireview: Not Picking Pockets: Nuclear Receptor Alternate-Site Modulators (NRAMs)
Terry W. Moore et al.
MOLECULAR ENDOCRINOLOGY (2010)
Hydrocarbon double-stapling remedies the proteolytic instability of a lengthy peptide therapeutic
Gregory H. Bird et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
AR Inhibitors Identified by High-Throughput Microscopy Detection of Conformational Change and Subcellular Localization
Jeremy O. Jones et al.
ACS CHEMICAL BIOLOGY (2009)
Alternative Inhibition of Androgen Receptor Signaling: Peptidomimetic Pyrimidines As Direct Androgen Receptor/Coactivator Disruptors
Jillian R. Gunther et al.
ACS CHEMICAL BIOLOGY (2009)
The biology of hormone refractory breast and prostate cancer An NCI workshop report
Suresh Mohla et al.
CANCER BIOLOGY & THERAPY (2009)
Computational design, synthesis, and evaluation of miniproteins as androgen receptor coactivator mimics
Belen Vaz et al.
CHEMICAL COMMUNICATIONS (2009)
Perturbation of Estrogen Receptor α Localization with Synthetic Nona-Arginine LXXLL-Peptide Coactivator Binding Inhibitors
Maelle Carraz et al.
CHEMISTRY & BIOLOGY (2009)
Differential Presentation of Protein Interaction Surfaces on the Androgen Receptor Defines the Pharmacological Actions of Bound Ligands
John David Norris et al.
CHEMISTRY & BIOLOGY (2009)
Improvement of Pharmacological Properties of Irreversible Thyroid Receptor Coactivator Binding Inhibitors
Jong Yeon Hwang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Covalent Modifiers: An Orthogonal Approach to Drug Design
Michele H. Potashman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Cyclic Pyrrole-Imidazole Polyamides Targeted to the Androgen Response Element
David M. Chenoweth et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
Synthesis of Biphenyl Proteomimetics as Estrogen Receptor-α Coactivator Binding Inhibitors
Anna B. Williams et al.
ORGANIC LETTERS (2009)
Elucidating the 'Jekyll and Hyde' Nature of PXR: The Case for Discovering Antagonists or Allosteric Antagonists
Arunima Biswas et al.
PHARMACEUTICAL RESEARCH (2009)
Inhibition of prostate cancer cell growth by second-site androgen receptor antagonists
James D. Joseph et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Non-competitive androgen receptor inhibition in vitro and in vivo
Jeremy O. Jones et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
Chris Tran et al.
SCIENCE (2009)
Amphipathic benzenes are designed inhibitors of the estrogen receptor α/steroid receptor coactivator interaction
Jillian R. Gunther et al.
ACS CHEMICAL BIOLOGY (2008)
A cellular conformation-based screen for androgen receptor inhibitors
Jeremy O. Jones et al.
ACS CHEMICAL BIOLOGY (2008)
Synthesis and biological evaluation of guanylhydrazone coactivator binding inhibitors for the estrogen receptor
Andrew L. LaFrate et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Implications of the binding of tamoxifen to the coactivator recognition site of the estrogen receptor
Douglas J. Kojetin et al.
ENDOCRINE-RELATED CANCER (2008)
A new small molecule inhibitor of estrogen receptor α binding to estrogen response elements blocks estrogen-dependent growth of cancer cells
Chengjian Mao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Blocking Estrogen Signaling After the Hormone: Pyrimidine-Core Inhibitors of Estrogen Receptor-Coactivator Binding
Alexander A. Parent et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
The phytoestrogen Coumestrol is a naturally occurring antagonist of the human pregnane x receptor
Hongwei Wang et al.
MOLECULAR ENDOCRINOLOGY (2008)
Computational discovery of novel low micromolar human pregnane X receptor antagonists
Sean Ekins et al.
MOLECULAR PHARMACOLOGY (2008)
Sintokamides A to E, Chlorinated Peptides from the Sponge Dysidea sp that Inhibit Transactivation of the N-Terminus of the Androgen Receptor in Prostate Cancer Cells
Marianne D. Sadar et al.
ORGANIC LETTERS (2008)
Molecular characterization of a B-ring unsaturated estrogen: Implications for conjugated equine estrogen components of Premarin
Robert W. Hsieh et al.
STEROIDS (2008)
Structural insight into the mode of action of a direct inhibitor of coregulator binding to the thyroid hormone receptor
Eva Estebanez-Perpina et al.
MOLECULAR ENDOCRINOLOGY (2007)
Inhibitors of the interaction of a thyroid hormone receptor and coactivators:: Preliminary structure-activity relationships
Leggy A. Arnold et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
A surface on the androgen receptor that allosterically regulates coactivator binding
Eva Estebanez-Perpina et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The nuclear receptor-coactivator interaction surface as a target for peptide antagonists of the peroxisome proliferator-activated receptors
Niharika B. Mettu et al.
MOLECULAR ENDOCRINOLOGY (2007)
Perspectives on designs of antiandrogens for prostate cancer
Eva Estebanez-Perpina et al.
EXPERT OPINION ON DRUG DISCOVERY (2007)
Bicyclo [2.2.2] octanes: Close structural mimics of the nuclear receptor-binding motif of steroid receptor coactivators
Hai-Bing Zhou et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Nuclear receptor coregulators and human disease
David M. Lonard et al.
ENDOCRINE REVIEWS (2007)
Suppression of androgen receptor-mediated gene expression by a sequence-specific DNA-binding polyamide
Nicholas G. Nickols et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Activated pregnenolone X-receptor is a target for ketoconazole and its analogs
Hongwei Wang et al.
CLINICAL CANCER RESEARCH (2007)
Crystal structure of the PXR-T1317 complex provides a scaffold to examine the potential for receptor antagonism
Yu Xue et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Androgen receptor decoy molecules block the growth of prostate cancer
Steven N. Quayle et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Helix mimetics as inhibitors of the interaction of the estrogen receptor with coactivator peptides
Jorge Becerril et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2007)
Human pregnane X receptor antagonists and Agonists define molecular requirements for different binding sites
Sean Ekins et al.
MOLECULAR PHARMACOLOGY (2007)
Inhibition of drug metabolism by blocking the activation of nuclear receptors by ketoconazole
H. Huang et al.
ONCOGENE (2007)
XR5944: A potent inhibitor of estrogen receptors
Chandanamali Punchihewa et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Disruption of estrogen receptor DNA-binding domain and related intramolecular communication restores tamoxifen sensitivity in resistant breast cancer
Li Hua Wang et al.
CANCER CELL (2006)
Overview of nomenclature of nuclear receptors
Pierre Germain et al.
PHARMACOLOGICAL REVIEWS (2006)
Cross-talk between nuclear receptors and nuclear factor κB
K. De Bosscher et al.
ONCOGENE (2006)
Opinion - Drugs, their targets and the nature and number of drug targets
Peter Imming et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Ligand-independent androgen receptor activity is activation function-2-independent and resistant to antiandrogens in androgen refractory prostate cancer cells
Scott M. Dehm et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Androgen receptor ligand-binding domain interaction and nuclear receptor specificity of FXXLF and LXXLL motifs as determined by L/F swapping
Hendrikus J. Dubbink et al.
MOLECULAR ENDOCRINOLOGY (2006)
Novel FXXFF and FXXMF motifs in androgen receptor cofactors mediate high affinity and specific interactions with the ligand-binding domain
Dennis J. van de Wijngaart et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
A second binding site for hydroxytamoxifen within the coactivator-binding groove of estrogen receptor β
Yong Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Targeting protein-protein interactions by rational design: mimicry of protein surfaces
Steven Fletcher et al.
JOURNAL OF THE ROYAL SOCIETY INTERFACE (2006)
Substituted 1,4-benzodiazepine-2,5-diones as α-helix mimetic antagonists of the HDM2-p53 protein-protein interaction
MD Cummings et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2006)
Issues related to targeted delivery of proteins and peptides
Yingjuan Lu et al.
AAPS JOURNAL (2006)
Discovery of small molecule inhibitors of the interaction of the thyroid hormone receptor with transcriptional coregulators
LA Arnold et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Potent inhibitors of LXXLL-based protein-protein interactions
AK Galande et al.
CHEMBIOCHEM (2005)
Investigations on gossypol: past and present developments
K Dodou
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2005)
Development of peptide antagonists for the androgen receptor using combinatorial peptide phage display
CY Chang et al.
MOLECULAR ENDOCRINOLOGY (2005)
Androgen receptor - cofactor interactions as targets for new drug discovery
CY Chang et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2005)
Inhibition of DNA binding by human estrogen-related receptor 2 and estrogen receptor α with minor groove binding polyamides
MD Gearhart et al.
BIOCHEMISTRY (2005)
Delineation of a unique protein-protein interaction site on the surface of the estrogen receptor
EH Kong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The molecular mechanisms of coactivator utilization in ligand-dependent transactivation by the androgen receptor
E Estébanez-Perpiña et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Identification of novel estrogen receptor α antagonists
DL Shao et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2004)
Small-molecule inhibitors of protein-protein interactions: Progressing towards the dream
MR Arkin et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Selective LXXLL peptides antagonize transcriptional activation by the retinoid-related orphan receptor RORγ
S Kurebayashi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Thioether side chain cyclization for helical peptide formation: inhibitors of estrogen receptor-coactivator interactions
AK Galande et al.
JOURNAL OF PEPTIDE RESEARCH (2004)
Design, synthesis, and in vitro biological evaluation of small molecule inhibitors of estrogen receptor a coactivator binding
AL Rodriguez et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Recognition and accommodation at the androgen receptor coactivator binding interface
E Hur et al.
PLOS BIOLOGY (2004)
Distinct recognition modes of FXXLF and LXXLL motifs by the androgen receptor
HJ Dubbink et al.
MOLECULAR ENDOCRINOLOGY (2004)
Identification of an alternative ligand-binding pocket in the nuclear vitamin D receptor and its functional importance in 1α,25(OH)2-vitamin D3 signaling
MT Mizwicki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Suppression of breast cancer by chemical modulation of vulnerable zinc fingers in estrogen receptor
LH Wang et al.
NATURE MEDICINE (2004)
Structural basis for androgen receptor interdomain and coactivator interactions suggests a transition in nuclear receptor activation function dominance
B He et al.
MOLECULAR CELL (2004)
Principles for modulation of the nuclear receptor superfamily
H Gronemeyer et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Helix-stabilized cyclic peptides as selective inhibitors of steroid receptor-coactivator interactions
AM Leduc et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Discovery, characterization, and structure - Activity relationships studies of proapoptotic polyphenols targeting B-cell lymphocyte/leukemia-2 proteins
S Kitada et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
The use of phage display technique for the isolation of androgen receptor interacting peptides with (F/W)XXL(F/W) and FXXLY new signature motifs
CL Hsu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Novel selective inhibitors of the interaction of individual nuclear hormone receptors with a mutually shared steroid receptor coactivator 2
TR Geistlinger et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2003)
Small molecule modulators of histone acetyltransferase p300
K Balasubramanyam et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Synthetic LXXLL peptides antagonize 1′25-dihydroxyvitamin D3-dependent transcription
JW Pike et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2003)
Design of thyroid hormone receptor antagonists from first principles
P Webb et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2002)
Amino acids 3-13 and amino acids in and flanking the 23FxxLF27 motif modulate the interaction between the N-terminal and ligand-binding domain of the androgen receptor
K Steketee et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2002)
Inhibition of 1,25-dihydroxyvitamin D3-dependent transcription by synthetic LXXLL peptide antagonists that target the activation domains of the vitamin D and retinoid X receptors
P Pathrose et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2002)
Fulvestrant ('Faslodex') - a new treatment option for patients progressing on prior endocrine therapy
C Morris et al.
ENDOCRINE-RELATED CANCER (2002)
Ligand-independent activation of the androgen receptor by interleukin-6 and the role of steroid receptor coactivator-1 in prostate cancer cells
T Ueda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Putative role of the orphan nuclear receptor SXR (steroid and xenobiotic receptor) in the mechanism of CYP3A4 inhibition by xenobiotics
A Takeshita et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition
RK Bledsoe et al.
CELL (2002)
PXR, CAR and drug metabolism
TM Willson et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
Evaluation of ligand-dependent changes in AR structure using peptide probes
CY Chang et al.
MOLECULAR ENDOCRINOLOGY (2002)
The FXXLF motif mediates androgen receptor-specific interactions with coregulators
B He et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Structure-activity relationships for inhibition of human 5α-reductases by polyphenols
RA Hiipakka et al.
BIOCHEMICAL PHARMACOLOGY (2002)
Structure-based design and synthesis of a thyroid hormone receptor (TR) antagonist
JD Baxter et al.
ENDOCRINOLOGY (2002)
Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways
T Ueda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Preventing estrogen receptor action with dimer-interface peptides
MR Yudt et al.
STEROIDS (2001)
Oral gossypol in the treatment of patients with refractory metastatic breast cancer: A phase I/II clinical trial
C Van Poznak et al.
BREAST CANCER RESEARCH AND TREATMENT (2001)
An inhibitor of the interaction of thyroid hormone receptor β and glucocorticoid interacting protein 1
TR Geistlinger et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2001)
Reactivity of zinc finger cores: Analysis of protein packing and electrostatic screening
AT Maynard et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2001)
Development of peptide antagonists that target estrogen receptor β-coactivator interactions
JM Hall et al.
MOLECULAR ENDOCRINOLOGY (2000)
Structural evidence for ligand specificity in the binding domain of the human androgen receptor -: Implications for pathogenic gene mutations
PM Matias et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor
B He et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Preferential oxidation of zinc finger 2 in estrogen receptor DNA-binding domain prevents dimerization and, hence, DNA binding
RM Whittal et al.
BIOCHEMISTRY (2000)
Selection of estrogen receptor β- and thyroid hormone receptor β-specific coactivator-mimetic peptides using recombinant peptide libraries
JP Northrop et al.
MOLECULAR ENDOCRINOLOGY (2000)
分享论文
